Inventor · disambiguated record
Francine Zhifen Chen
Also filed as: CHEN FRANCINE · CHEN FRANCINE Z · CHEN FRANCINE ZHIFEN
14 granted patents·5 pending applications·233 citations·filing 2002–2024
93Inventor score
Files withMACROGENICS INC10AMGEN FREMONT INC2JOHNSON LESLIE S2LANDES GREGORY M2CELLDEX THERAPEUTICS INC1
Top patents by PatentIndex Score
19 records- 0197US8802091B2Antibodies reactive with B7-H3 and uses thereofJOHNSON LESLIE S·Filed 2012·Granted Aug 12, 2014·54 cites·10 claims
- 0296US9150656B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofJOHNSON LESLIE S·Filed 2011·Granted Oct 6, 2015·47 cites·28 claims
- 0395US9896508B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2016·Granted Feb 20, 2018·8 cites·12 claims
- 0493US9441049B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2014·Granted Sep 13, 2016·10 cites·11 claims
- 0593US7135174B2Antibodies directed to PDGFD and uses thereofAMGEN FREMONT INC·Filed 2002·Granted Nov 14, 2006·47 cites·4 claims
- 0691US9714296B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·7 cites·27 claims
- 0790US9714295B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·6 cites·27 claims
- 0889US10683364B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2017·Granted Jun 16, 2020·3 cites·20 claims
- 0989US2024409661A1Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses ThereofMACROGENICS INC·Filed 2024·Application pending·0 cites
- 1087US8067544B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2004·Granted Nov 29, 2011·37 cites·18 claims
- 1185US7572444B2Binding proteins specific for human matriptaseAMGEN FREMONT INC·Filed 2005·Granted Aug 11, 2009·12 cites·17 claims
- 1276US9932400B2Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereofMACROGENICS INC·Filed 2014·Granted Apr 3, 2018·2 cites·20 claims
- 1372US2020377612A1Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses ThereofMACROGENICS INC·Filed 2020·Application pending·0 cites
- 1469US10730945B2Antibodies reactive with B7-H3 and users thereofMACROGENICS INC·Filed 2018·Granted Aug 4, 2020·0 cites·20 claims
- 1562US10858430B2Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereofMACROGENICS INC·Filed 2017·Granted Dec 8, 2020·0 cites·20 claims
- 1651US2024165256A1Methods for increasing efficacy of immunoconjugates targeting adam9 for the treatment of cancerIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 1750US2017218067A1Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1849US9580503B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2011·Granted Feb 28, 2017·0 cites·16 claims
- 1947US2006293506A1Antibodies directed to PDGFD and uses thereofCORVALAN JOSE R·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →